Drugs / IVMED-85
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT07370584 | Feb → May 2026 overdue | — | iVeena Delivery Systems, Inc. | Recruiting | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT05761795 | Feb 2024 → May 2026 overdue | myopia | iVeena Delivery Systems, Inc. | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IVMED-85 | “Efficacy of IVMED-85 on Pediatric Myopia” NCT05761795 ↗ |
| Route | Topical | “Eye drop” NCT05761795 ↗ |